NCT06734286 Working Memory Training in Patients with Mild Cognitive Impairment
| NCT ID | NCT06734286 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Joseph's Hospital and Medical Center, Phoenix |
| Condition | Mild Cognitive Impairment (MCI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-09-16 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-09-16 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).
Eligibility Criteria
Inclusion Criteria: 1. Male or female outpatients ages ≥ 50 years; 2. Meet Mayo Clinic Criteria for MCI. (Patients with mild cognitive impairment) 3. Access to the internet through computer 4. A proficiency in speaking and reading English or having a family member who is proficient in reading and speaking English and is willing to serve as a translator. 5. Vision and hearing must be sufficient to comply with study procedures. Exclusion Criteria: 1. Mini Mental State Exam (MMSE) score less than 19 or patients diagnosed with moderate or severe dementia by a clinician. 2. In the opinion of the investigator, participation would not be in the best interest of the subject.
Contact & Investigator
Yonas E Geda, M.D, MSc
PRINCIPAL INVESTIGATOR
Barrow Neurological Institute, Alzheimer's Disease and Cognitive Disorders Division
Frequently Asked Questions
Who can join the NCT06734286 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Mild Cognitive Impairment (MCI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734286 currently recruiting?
Yes, NCT06734286 is actively recruiting participants. Contact the research team at yonas.geda@commonspirit.org for enrollment information.
Where is the NCT06734286 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT06734286 clinical trial?
NCT06734286 is sponsored by St. Joseph's Hospital and Medical Center, Phoenix. The principal investigator is Yonas E Geda, M.D, MSc at Barrow Neurological Institute, Alzheimer's Disease and Cognitive Disorders Division. The trial plans to enroll 10 participants.